Sanofi Expands Insulin Affordability Initiative in the U.S. with $35 Monthly Cap for All Patients

Sanofi US announced on September 26 that its "Insulins Valyou Savings Program" would significantly expand its coverage. Any U.S. patient with a valid prescription can purchase a 30-day supply of any Sanofi insulin for $35. The program, initially established for the uninsured, will now be open to all Americans regardless of their insurance status—including those with commercial insurance or Medicare. The expanded "Insulins Valyou Savings Program" now ensures that every U.S. patient pays no more than $35 per month for Sanofi insulin.